Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
NEW YORK (
) -- The ex-dividend date for
) is tomorrow, June 28, 2013. Owners of shares as of market close today will be eligible for a dividend of 30 cents per share. At a price of $61.62 as of 9:31 a.m. ET, the dividend yield is 2%.
The average volume for Quest has been 1.3 million shares per day over the past 30 days. Quest has a market cap of $9.61 billion and is part of the health care sector and health services industry. Shares are up 5% year to date as of the close of trading on Wednesday.
Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. The company has a P/E ratio of 16.6, below the S&P 500 P/E ratio of 17.7.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.